[Biological methods of predicting the effectiveness of psychopharmacologic treatment of schizophrenia (review)].
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001058:Apomorphine; D000242:Cyclic AMP / Q000134:cerebrospinal fluid; D004341:Drug Evaluation / Q000379:methods; D004569:Electroencephalography; D005071:Evoked Potentials; D005712:Galvanic Skin Response; D013006:Growth Hormone / Q000378:metabolism; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D008995:Monoamine Oxidase / Q000032:analysis; D011379:Prognosis; D012559:Schizophrenia / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D012894:Sleep Stages
D014150:Antipsychotic Agents; D006897:Hydroxyindoleacetic Acid; D013006:Growth Hormone; D000242:Cyclic AMP; D008995:Monoamine Oxidase; D001058:Apomorphine; D006719:Homovanillic Acid
Biologicheskie metody prognoza éffektivnosti psikhofarmakoterapii bol'nykh shizofrenieĭ (obzor).